Every SEC Form 3/4/5 on record for this filer (CIK 1667657) — 5 issuers, 29 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| DHR | DANAHER CORP /DE/ | SVP, Chief Science Officer | 2020-12-21 → 2026-03-03 | 24 | −$268,914 |
| BCYC | BICYCLE THERAPEUTICS PLC | Director | 2021-03-19 → 2026-01-06 | 7 | — |
| EVLO | Evelo Biosciences, Inc. | Director · lapsed | 2019-06-14 → 2023-06-12 | 5 | — |
| MNTA | MOMENTA PHARMACEUTICALS INC | Director · lapsed | 2016-03-10 → 2020-10-01 | 9 | −$814,475 |
| SYBX | SYNLOGIC, INC. | See Remarks · Director · lapsed | 2017-08-30 → 2018-03-16 | 3 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
3 of 5 issuers are covered and open a security page; the rest are on file here only.